Retention of HIV-infected children on antiretroviral treatment in HIV care and treatment programs in Kenya, Mozambique, Rwanda, and Tanzania.
about
Survival Outcomes in a Pediatric Antiretroviral Treatment Cohort in Southern MalawiGetting to 90-90-90 in paediatric HIV: What is needed?Poor clinical outcomes for HIV infected children on antiretroviral therapy in rural Mozambique: need for program quality improvement and community engagementAntiretroviral treatment program retention among HIV-infected children in the Democratic Republic of CongoPaediatric HIV care in sub-Saharan Africa: clinical presentation and 2-year outcomes stratified by age group.Immunodeficiency in children starting antiretroviral therapy in low-, middle-, and high-income countries.Outcomes of Infants Starting Antiretroviral Therapy in Southern Africa, 2004-2012.Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age.Long-term outcomes of a pediatric HIV treatment program in Maputo, Mozambique: a cohort study.Retention of HIV-Infected Children in the First 12 Months of Anti-Retroviral Therapy and Predictors of Attrition in Resource Limited Settings: A Systematic Review.Tracing defaulters in HIV prevention of mother-to-child transmission programmes through community health workers: results from a rural setting in Zimbabwe.The clock is ticking: the rate and timeliness of antiretroviral therapy initiation from the time of treatment eligibility in Kenya.Implementation and Operational Research: Early Tracing of Children Lost to Follow-Up From Antiretroviral Treatment: True Outcomes and Future Risks.Clinical decision tools are needed to identify HIV-positive patients at high risk for poor outcomes after initiation of antiretroviral therapy.Patching the gaps towards the 90-90-90 targets: outcomes of Nigerian children receiving antiretroviral treatment who are co-infected with tuberculosis.90-90-90--Charting a steady course to end the paediatric HIV epidemic.Implementation of antiretroviral therapy guidelines for under-five children in Tanzania: translating recommendations into practice.Antiretroviral treatment, management challenges and outcomes in perinatally HIV-infected adolescentsFactors associated with long-term antiretroviral therapy attrition among adolescents in rural Uganda: a retrospective studyCaregiver satisfaction with paediatric HIV treatment and care in Nigeria and equity implications for children living with HIV.Use of a Comprehensive HIV Care Cascade for Evaluating HIV Program Performance: Findings From 4 Sub-Saharan African Countries.Decentralization of HIV care and treatment services in Central Province, Kenya.Turnaround time for early infant HIV diagnosis in rural Zambia: a chart review.Factors Determining Survival and Retention among HIV-Infected Children and Adolescents in a Community Home-Based Care and a Facility-Based Family-Centred Approach in Kampala, Uganda: A Cohort Study.Transition from paediatric to adult care of adolescents living with HIV in sub-Saharan Africa: challenges, youth-friendly models, and outcomes.Antiretroviral Therapy in Children Less Than 24 Months of Age at Pediatric HIV Centers in Tanzania: 12-Month Clinical Outcomes and Survival.Survival of HIV-1 vertically infected children.Outcomes among HIV-infected children initiating HIV care and antiretroviral treatment in Ethiopia.Despite Access to Antiretrovirals for Prevention and Treatment, High Rates of Mortality Persist Among HIV-infected Infants and Young Children.Targeting 90-90-90--don't leave children and adolescents behind.Validity of reported retention in antiretroviral therapy after roll-out to peripheral facilities in Mozambique: Results of a retrospective national cohort analysis.Attrition among HIV positive children enrolled under integrated HIV care programme in Myanmar: 12 years cohort analysis
P2860
Q28553184-9C41E66C-0357-47B4-BC6E-3D871E2C2745Q30385352-F1E3707C-A77A-4907-B013-0746260B9364Q34374033-43D13457-463F-438B-97EE-961F3D2A1F87Q34775940-C68E3489-3E97-4414-99F0-2C3FDF3A0A8AQ34843384-378AC965-CE7F-4D96-A5EB-2A059FE58C4CQ35152574-578D1169-3646-4D3B-8C75-EDAAB9449C28Q35872045-AEAD4497-894B-4849-AFA5-0E076CBC5EE6Q35955127-D607E7C5-E114-4BD2-97AF-A18779FA6B96Q35969206-29CB7B98-B20C-4F50-A378-E2A3AB4C77D6Q36046415-7F16AAA3-84E0-4A5D-B3D4-D9DFEBE5CAB4Q36157709-174B2687-0750-4DCB-84FA-338B8AAAB02CQ36215535-EF0F94E1-0768-4F74-90A5-370153C19EA6Q36282732-AC7087C8-2AA2-4A2D-A0FE-5D85B035EFBEQ36349654-8CB15E76-5C9C-4E37-919E-8078CF37E686Q36349677-906ED37A-F705-4FA3-B78C-B8B1B1E219F2Q36349696-7F506C56-92C7-423B-A138-23FA793A638BQ36389935-DF5D7366-7AE0-4DF8-993F-EEFB6F0BD7F8Q36941659-7CEE0E60-D8BC-48B1-851A-EE96EAF3BDB6Q37116593-18D6E01D-2F55-44C4-8DEF-E51E4E4F2CC5Q37189588-E546AACA-33EC-48EA-9C38-930F8998755AQ37391454-C76E106B-AB33-4B49-8FC9-A69F03C318C9Q37412441-7428C448-1650-41A3-BF4B-6C3AB5D9B324Q37514382-186F1728-4794-41D3-8CB0-25A1DE8C93BFQ37730863-B67E4F1D-DEF9-48B6-B8BF-5A5BD0049EF4Q38370678-732F3FB2-9692-4A7F-8C6D-A0AEADB2E078Q38844460-53C9571D-19E8-405C-8FD3-536D08D5ED06Q38975088-6E5EC4CE-5414-4B13-98B5-4C2B6301F1B9Q39032531-0CB3FEB0-9C5D-403B-BF79-5BDCEDA654CCQ40394069-CB8CD780-845E-4E80-ADEB-19EFD7CED619Q43142354-6588CE9F-D1F0-4905-9BE3-5207EDEA080EQ55436397-42228953-857C-4435-884B-160DA12759B1Q58759040-5C9FE877-BD2F-4111-821B-C560FDEE4B8C
P2860
Retention of HIV-infected children on antiretroviral treatment in HIV care and treatment programs in Kenya, Mozambique, Rwanda, and Tanzania.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Retention of HIV-infected chil ...... ambique, Rwanda, and Tanzania.
@en
Retention of HIV-infected chil ...... ambique, Rwanda, and Tanzania.
@nl
type
label
Retention of HIV-infected chil ...... ambique, Rwanda, and Tanzania.
@en
Retention of HIV-infected chil ...... ambique, Rwanda, and Tanzania.
@nl
prefLabel
Retention of HIV-infected chil ...... ambique, Rwanda, and Tanzania.
@en
Retention of HIV-infected chil ...... ambique, Rwanda, and Tanzania.
@nl
P2093
P2860
P921
P1476
Retention of HIV-infected chil ...... ambique, Rwanda, and Tanzania.
@en
P2093
Eduarda Gusmao
Gilbert Tene
Identifying Optimal Models of HIV Care and Treatment in Sub-Saharan Africa Consortium
Margaret L McNairy
Matthew R Lamb
Millembe Panya
Mushin Sheriff
Rosalind J Carter
Ruby Fayorsey
Vincent Mutabazi
P2860
P304
P356
10.1097/QAI.0B013E318278BCB0
P407
P577
2013-03-01T00:00:00Z